These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Engineering Opportunities in Cancer Immunotherapy: After Decades of Missteps and Delays, a Growing Immune-Oncology Market and Improved Cancer Treatment Outcomes Open New Prospects for Biomedical Engineers and Data Scientists. Zaharoff DA IEEE Pulse; 2018; 9(4):8-11. PubMed ID: 30028678 [TBL] [Abstract][Full Text] [Related]
24. The response of urological tumours to immunotherapy. Gkialas I; Kalantzis A; Lykourinas M J BUON; 2005; 10(3):329-36. PubMed ID: 17357186 [TBL] [Abstract][Full Text] [Related]
25. Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy. Shah AH; Jusué-Torres I; Ivan ME; Komotar RJ; Kasahara N J Neurosurg; 2018 Apr; 128(4):1139-1146. PubMed ID: 28598280 [TBL] [Abstract][Full Text] [Related]
26. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Karbach J; Neumann A; Brand K; Wahle C; Siegel E; Maeurer M; Ritter E; Tsuji T; Gnjatic S; Old LJ; Ritter G; Jäger E Clin Cancer Res; 2012 Oct; 18(19):5449-59. PubMed ID: 22847809 [TBL] [Abstract][Full Text] [Related]
27. The 2013 William B. Coley Award for Distinguished Research In Basic and Tumor Immunology. Cancer Immunol Res; 2013 Dec; 1(6):362-4. PubMed ID: 24778129 [No Abstract] [Full Text] [Related]
28. Bacterial vaccine therapy of cancer. Nauts HC Dev Biol Stand; 1977 Apr 13-15; 38():487-94. PubMed ID: 608541 [No Abstract] [Full Text] [Related]
29. Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations. Kienle GS Glob Adv Health Med; 2012 Mar; 1(1):92-100. PubMed ID: 24278806 [TBL] [Abstract][Full Text] [Related]
30. The Intriguing History of Cancer Immunotherapy. Dobosz P; Dzieciątkowski T Front Immunol; 2019; 10():2965. PubMed ID: 31921205 [TBL] [Abstract][Full Text] [Related]
31. [The development of live vaccines in the Soviet Union. (Review) Live bacterial vaccines]. Kravchenko AT; Saltykov RA Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):3-9. PubMed ID: 4894102 [No Abstract] [Full Text] [Related]
33. William B. Coley: His Hypothesis, His Toxin, and the Birth of Immunotherapy. Loughlin KR Urol Clin North Am; 2020 Nov; 47(4):413-417. PubMed ID: 33008492 [TBL] [Abstract][Full Text] [Related]
34. Advances in strategies and methodologies in cancer immunotherapy. Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192 [TBL] [Abstract][Full Text] [Related]
35. The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933. Levine DB HSS J; 2008 Feb; 4(1):1-9. PubMed ID: 18751855 [TBL] [Abstract][Full Text] [Related]
36. Tumours and Coley's toxins. Rook G Nature; 1992 Jun; 357(6379):545. PubMed ID: 1608465 [No Abstract] [Full Text] [Related]
37. Historical note on bone and soft tissue sarcoma. Peltier LF J Surg Oncol; 1985 Dec; 30(4):201-5. PubMed ID: 3908827 [TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal immunotherapy: historical perspectives and modern therapy. Morano WF; Aggarwal A; Love P; Richard SD; Esquivel J; Bowne WB Cancer Gene Ther; 2016 Nov; 23(11):373-381. PubMed ID: 27834358 [TBL] [Abstract][Full Text] [Related]
39. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. NAUTS HC; SWIFT WE; COLEY BL Cancer Res; 1946 Apr; 6():205-16. PubMed ID: 21018724 [No Abstract] [Full Text] [Related]
40. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments]. Cussler K; Balks E ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]